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Background
This study examined the impact of CMR on clinical
management in patients with undergoing evaluation for
arrhythmogenic right ventricular dysplasia/cardiomyopa-
thy(ARVD/C).
Methods
Patients referred for assessment of ARVD/C were evalu-
ated. Using 2010 ARVD/C Task Force criteria, clinical
history, family history, ECG and other test results were
evaluated with and without CMR findings to determine
definite, borderline or possible ARVD/C. CMR included
assessment of right ventricular(RV) size, function, and
regional wall motion(RWM). For alternative diagnoses,
tissue characterization and late gadolinium enhancement
were routinely performed. Qp:Qs was performed when
intracardiac shunt was suspected by the supervising
physician.
Results
311 consecutive patients (mean age 45±14 years, 53%
male) were included. Prior to CMR, patients were classi-
fied as definite (n=1), borderline (n=1) or possible ARVD
(n=18, Table). After CMR, 6(2%) were diagnosed with
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definite ARVD/C and underwent defibrillator implanta-
tion, 5(2%) were classified as borderline ARVD/C, and
9 (3%) remained possible ARVD/C. 51(16%) had alterna-
tive diagnoses (Figure/Table), resulting in a management
change: 6(1.9%) patients had intracardiac shunt,
36(11.5%) had another cardiomyopathy or RV overload
state, and 9(2.8%) had other diagnoses. 76(24%) had RV
enlargement alone with normal RV function and absent
RWM by CMR while 164(53%) without other major cri-
teria had normal RV function, size, and RWM.
Conclusions
CMR impacted clinical management by contributing to
the diagnosis of definite or borderline ARVD/C in 4% of
patients and by excluding the presence of significant RV
dysfunction, enlargement, and RWM in over half of
patients. CMR identified important alternative diagnoses
in 16%.
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Table 1 Clinical Impact of CMR on Diagnosis of ARVD/C vs. Alternative Diagnoses
n=311 2010 Guidelines without CMR
Findings, n (%)
2010 Guidelines with CMR
Findings, n (%)
Definite Criteria for ARVD/C 1 (0.3) 6 (2)
Borderline Criteria for ARVD/C 1 (0.3) 5 (2)
Possible Criteria for ARVD/C 18 (5.8) 9 (3)
Patients with 1 or no Minor Criteria, not meeting 2010 Guidelines Definition of
\"Definite\”, \"Borderline\” or \"Possible\”






* Alternative Diagnosis Resulting in Change in Management included 6 (1.9%) Intracardiac shunts, other Cardiomyopathy or RV Overload State 36 (11.5%), or
Other Diagnosis 9 (2.8%)
**RV Enlargement Alone with normal RV Function and Regional Wall Motion
*** Normal RV Function, Size and Regional Wall Motion by CMR
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